TITLE 14. INSURANCE
REGISTRAR'S NOTICE: The
State Corporation Commission is claiming an exemption from the Administrative
Process Act in accordance with § 2.2-4002 A 2 of the Code of Virginia,
which exempts courts, any agency of the Supreme Court, and any agency that by
the Constitution is expressly granted any of the powers of a court of record.
Title of Regulation: 14VAC5-120. Rules Governing the
Implementation of the Individual Accident and Sickness Insurance Minimum
Standards Act with Respect to Specified Disease Policies (amending 14VAC5-120-70).
Statutory Authority: §§ 12.1-13 and 38.2-223 of the Code
of Virginia.
Effective Date: July 1, 2017.
Agency Contact: Elsie Andy, Principal Insurance Market
Examiner, Life and Health Division, Bureau of Insurance, State Corporation
Commission, P.O. Box 1157, Richmond, VA 23218, telephone (804) 371-9072, FAX
(804) 371-9944, or email elsie.andy@scc.virginia.gov.
Summary:
The amendments (i) align the indemnity coverage benefits
for various types of therapies used to treat cancer with a more flexible
benefit and payment structure applicable to specified disease policies and (ii)
reflect more up-to-date protocols and services for cancer treatment.
AT RICHMOND, MAY 16, 2017
COMMONWEALTH OF VIRGINIA, ex rel.
STATE CORPORATION COMMISSION
CASE NO. INS-2017-00032
Ex Parte: In the matter of Amending the Rules Governing
the Implementation of the Individual Accident and Sickness
Insurance Minimum Standards Act with Respect to Specified
Disease Policies
ORDER ADOPTING REVISIONS TO RULES
On March 16, 2017, the State Corporation Commission ("Commission")
issued an Order to Take Notice ("Order") to consider revisions to the
Rules Governing the Implementation of the Individual Accident and Sickness
Insurance Minimum Standards Act with Respect to Specified Disease Policies set
forth in Chapter 120 of Title 14 of the Virginia Administrative Code
("Rules").
The proposal to amend the Rules at 14 VAC 5-120-70 was
submitted to the Bureau of Insurance ("Bureau") by American Family
Life Assurance Company ("Aflac"), through its counsel. The proposed
amendments align the indemnity coverage benefits for various types of therapies
used to treat cancer with a more flexible benefit and payment structure.
Specifically, amendments to subdivisions 2 c (1) and (2) of section 70 of the
Rules reflect more up-to-date protocols and services for cancer treatment. The
Bureau reviewed and agreed with the proposal to amend the Rules in accordance
with Aflac's request.
The Order required that on or before May 5, 2017, any person
requesting a hearing on the amendments to the Rules shall have filed such
request for a hearing with the Clerk of the Commission
("Clerk"). No request for a hearing was filed with the Clerk.
The Order also required any interested persons to file with
the Clerk their comments in support of or in opposition to the amendments to
the Rules on or before May 5, 2017. No comments were filed with the Clerk.
NOW THE COMMISSION, having considered the proposed amendments
to the Rules, is of the opinion that the attached amendments to the Rules
should be adopted.
Accordingly, IT IS ORDERED THAT:
(1) The amendments to the Rules Governing the Implementation
of the Individual Accident and Sickness Insurance Minimum Standards Act with
Respect to Specified Disease Policies at Chapter 120 of Title 14 of the
Virginia Administrative Code, which amend the Rules at 14 VAC 5-120-70, and
which are attached hereto and made a part hereof, are hereby ADOPTED to be
effective July 1, 2017.
(2) The Bureau forthwith shall give notice of the adoption of
the amendments to the Rules to all insurers licensed by the Commission to write
accident and sickness insurance in the Commonwealth of Virginia, and to all
interested persons.
(3) The Commission's Division of Information Resources
forthwith shall cause a copy of this Order, together with the final amended
Rules, to be forwarded to the Virginia Registrar of Regulations for appropriate
publication in the Virginia Register of Regulations.
(4) The Commission's Division of Information Resources shall
make available this Order and the attached amendments to the Rules on the
Commission's website: http://www.scc.virginia.gov/case.
(5) The Bureau shall file with the Clerk of the Commission an
affidavit of compliance with the notice requirements of Ordering Paragraph (2)
above.
(6) This case is dismissed, and the papers herein shall be
placed in the file for ended causes.
AN ATTESTED COPY hereof shall be sent by the Clerk of the
Commission to: Kiva B. Pierce, Assistant Attorney General, Office of
the Attorney General, Division of Consumer Counsel, 202 N. 9th Street, 8th
Floor, Richmond, Virginia 23219-3424; and a copy hereof shall be delivered to
the Commission's Office of General Counsel and the Bureau of Insurance in care
of Deputy Commissioner Julie Blauvelt.
14VAC5-120-70. Specified disease minimum benefit standards.
No specified disease policy shall be delivered or issued for
delivery in this Commonwealth which that does not meet the
following minimum benefit standards. If the policy does not meet the required
minimum standards, it shall not be offered for sale. These are minimum benefit
standards and do not preclude the inclusion of other benefits which that
are not inconsistent with these standards.
1. Minimum benefit standards applicable to non-cancer
coverage:
a. A policy must provide coverage for each person insured
under the policy on an expense incurred basis for a specifically named
disease(s). This coverage must be in amounts not in excess of the usual and
customary charges, with a deductible amount not in excess of $250, an overall
aggregate benefit limit of not less than $5,000, a uniform percentage of
covered expenses that the insurer will pay of not less than 20% in increments
of 10%, no inside benefit limits and a benefit period of not less than two
years for at least the following:
(1) Hospital room and board and any other hospital furnished
medical services or supplies;
(2) Treatment by a legally qualified physician or surgeon;
(3) Private duty services of a registered nurse (R.N.);
(4) X-ray, radium and other therapy procedures used in
diagnosis and treatment;
(5) Professional ambulance for local service to or from a
local hospital;
(6) Blood transfusions, including expense incurred for blood
donors;
(7) Drugs and medicines prescribed by a physician;
(8) The rental of an iron lung or similar mechanical
apparatus;
(9) Braces, crutches and wheel chairs as are deemed necessary
by the attending physician for the treatment of the disease;
(10) Emergency transportation if in the opinion of the
attending physician it is necessary to transport the insured to another
locality for treatment of the disease; and
(11) May include coverage of any other expenses necessarily
incurred in the treatment of the disease; or
b. A policy must provide coverage for each person insured
under the policy for a specifically named disease(s) with no deductible amount,
and an overall aggregate benefit limit of not less than $25,000 payable at the
rate of not less than $50 a day while confined in a hospital and a benefit
period of not less than 500 days; or
c. A policy must provide lump-sum indemnity coverage of at
least $1,000. It must provide benefits which that are payable as
a fixed, one-time payment made within 30 days of submission to the insurer of
proof of diagnosis of the specified disease(s). Dollar benefits shall be
offered for sale only in even increments of $100 (i.e., $1,100, $1,200,
$1,300 . . .).
Where coverage is advertised or otherwise represented to offer
generic coverage of a disease(s) (e.g., "heart disease insurance"),
the same dollar amounts must be payable regardless of the particular subtype of
the disease. However, in the case of clearly identifiable subtypes with
significantly lower treatment costs, lesser amounts may be payable so long as
the policy clearly differentiates that subtype and its benefits.
2. Minimum benefit standards applicable to cancer only or
cancer combination coverage:
a. A policy must provide coverage for each person ensured
under the policy for cancer-only coverage or in combination with one or more
other specified diseases on an expense incurred basis for services, supplies,
care and treatment that are ordered or are prescribed by a physician as
necessary for the treatment of cancer. This coverage must be in amounts not in
excess of the usual and customary charges, with a deductible amount not in
excess of $250, an overall aggregate benefit limit of not less than $10,000, a
uniform percentage of covered expenses that the insurer will pay of not less
than 20% in increments of 10%, no inside benefit limits and a benefit period of
not less than three years for at least the following:
(1) Treatment by, or under the direction of, a legally
qualified physician or surgeon;
(2) X-ray, radium, chemotherapy and other therapy procedures
used in diagnosis and treatment;
(3) Hospital room and board and any other hospital furnished
medical services or supplies;
(4) Blood transfusions, and the administration thereof,
including expense incurred for blood donors;
(5) Drugs and medicines prescribed by a physician;
(6) Professional ambulance for local service to or from a
local hospital;
(7) Private duty services of a registered nurse (R.N.) provided
in a hospital; and
(8) May include coverage of any other expenses necessarily
incurred in the treatment of the disease; or
b. A policy must provide benefits for each person insured
under the policy for the following:
(1) Hospital confinement in an amount of at least $100 per day
for at least 500 days;
(2) Surgical expenses not to exceed an overall lifetime
maximum of $3,500; and
(3) Radium, cobalt, chemotherapy, or X-ray x-ray
therapy expenses as an outpatient to at least $1,000. Such therapy benefit
shall be restored after an insured is treatment or hospitalization free for at
least 12 months; or
c. A policy must provide per diem indemnity coverage.
(1) Such coverage must provide covered persons:
(a) A fixed-sum payment of at least $100 for each day
of hospital confinement for at least 365 days; and
(b) A fixed-sum payment equal to at least ½ the hospital
inpatient benefit for each day of hospital or non-hospital inpatient
or outpatient surgery, chemotherapy and radiation therapy for at least
365 days of treatment; and
(c) A fixed-sum payment made on the basis of a specified
period of time for any chemotherapy, radiation therapy, or other similar
therapy used to treat the disease.
(2) Benefits tied to confinement in a skilled nursing home
facility or to receipt of home health care are optional. If a policy
offers these benefits, they it must equal the following provide:
(a) A fixed-sum payment equal to at least ¼ the hospital
inpatient benefit for each day of skilled nursing home facility
confinement for at least 100 days; and
(b) A fixed-sum payment equal to at least ¼ the hospital
inpatient benefit for each day of home health care for at least 100 days;.
(c) Notwithstanding any other provision of this
chapter, any restriction or limitation applied to the benefits in subdivisions 2c(2)(a)
2 c (2) (a) and 2c(2)(b) above 2 c (2) (b), whether by
definition or otherwise, shall be no more restrictive than those under
Medicare; or
d. A policy must provide lump-sum indemnity coverage of at
least $1,000. It must provide benefits which that are payable as
a fixed, one-time payment made within 30 days of submission to the insurer of
proof of diagnosis of the specified disease(s). Dollar benefits shall be
offered for sale only in even increments of $100 (i.e., $1,100, $1,200, $1,300
. . .).
Where coverage is advertised or otherwise represented to
offer generic coverage of a disease(s) (e.g., "cancer insurance"),
the same dollar amounts must be payable regardless of the particular subtype of
the disease (e.g., lung or bone cancer). However, in the case of clearly
identifiable subtypes with significantly lower treatment costs (e.g., skin
cancer), lesser amounts may be payable so long as the policy clearly
differentiates that subtype and its benefits.
VA.R. Doc. No. R17-5058; Filed May 18, 2017, 12:36 p.m.